The failures and challenges of bone metastases research in radiation oncology
- PMID: 26909275
- PMCID: PMC4723364
- DOI: 10.1016/j.jbo.2013.04.003
The failures and challenges of bone metastases research in radiation oncology
Abstract
Bone metastases affect a large portion of the cancer population. As treatment options continue to evolve, many added failures and challenges arise. This narrative review details such in palliative radiation therapy for bone metastases. We begin by describing the incidence rates of bone metastases in the cancer population, the current standards of practice in recent literature and clinical trial data. Inconsistencies in end point definitions along with difficulties in measuring response to treatment and controversial areas are outlined. Current literature suggests that there is a discrepancy in physician and patient perspective on treatment options as well as quality of life. The added challenges of treatment side effects are addressed and a review of recent trials is given. Stereotactic radiation therapy is a relatively new treatment option for patients with bone metastases. Therefore, a review of the safety and efficacy of this treatment is provided. Other new areas of bone metastases treatment and research such as high intensity focused ultrasound and nanoparticles are discussed. Physicians need to prevent unwanted side effects of treatment in addition to determining how to integrate many new upcoming treatment options for patients with bone metastases. A continued reluctance to practice evidence based medicine needs to be addressed.
Keywords: Bone metastasis; Challenge; Clinical trial; Failure; Radiotherapy.
Similar articles
-
The added challenges of bone metastases treatment in elderly patients.Clin Oncol (R Coll Radiol). 2013 May;25(5):283-9. doi: 10.1016/j.clon.2012.11.001. Epub 2012 Nov 27. Clin Oncol (R Coll Radiol). 2013. PMID: 23199578
-
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.J Clin Oncol. 2000 Mar;18(6):1378-91. doi: 10.1200/JCO.2000.18.6.1378. J Clin Oncol. 2000. PMID: 10715310
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
Stereotactic body radiotherapy in the management of painful bone metastases.Oncology (Williston Park). 2008 Jun;22(7):782-8; discussion 788-9, 796-7. Oncology (Williston Park). 2008. PMID: 18619121 Review.
-
Update on radiation treatment for cancer pain.Curr Opin Support Palliat Care. 2007 Apr;1(1):11-5. doi: 10.1097/SPC.0b013e328133f5d8. Curr Opin Support Palliat Care. 2007. PMID: 18660718 Review.
Cited by
-
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes.Oncotarget. 2016 Dec 27;7(52):86522-86535. doi: 10.18632/oncotarget.13287. Oncotarget. 2016. PMID: 27852031 Free PMC article.
-
Focused ultrasound for the treatment of bone metastases: effectiveness and feasibility.J Ther Ultrasound. 2018 Nov 30;6:8. doi: 10.1186/s40349-018-0117-3. eCollection 2018. J Ther Ultrasound. 2018. PMID: 30519467 Free PMC article.
-
Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology.BMC Med Inform Decis Mak. 2021 Jul 12;21(1):212. doi: 10.1186/s12911-021-01568-w. BMC Med Inform Decis Mak. 2021. PMID: 34247596 Free PMC article. Review.
-
Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients.Med J Islam Repub Iran. 2019 Dec 19;33:142. doi: 10.34171/mjiri.33.142. eCollection 2019. Med J Islam Repub Iran. 2019. PMID: 32280648 Free PMC article.
-
Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.Cell Biol Toxicol. 2020 Apr;36(2):115-130. doi: 10.1007/s10565-019-09483-7. Epub 2019 Jun 27. Cell Biol Toxicol. 2020. PMID: 31250347 Free PMC article. Review.
References
-
- Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer. 2011;118(5):1457–1465. - PubMed
-
- Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone. 1991;12(1):S9–10. - PubMed
-
- Janjan N. Bone metastases: approaches to management. Seminars in Oncology. 2001;28(4 Suppl. 11):28–34. - PubMed
-
- Chow E., Fan G., Hadi S., Filipczak L. Symptom clusters in cancer patients with bone metastases. Supportive Care in Cancer. 2007 Sep;15(9):1035–1043. - PubMed
-
- Tong D., Gillick L., Hendrickson F.R. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982;50(5):893–899. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials